UPDATE - Auriga Downgraded HCA Holdings (HCA) to Hold; Macro Issues Moderate, But Still Present Over Next 12 Months

UPDATE - Auriga downgraded HCA Holdings (NYSE: HCA) from Buy to Hold, maintains target of $28.00.

Auriga analyst said, "In a nutshell we believe the macro issues HCA and the other hospital companies have faced have moderated but not disappeared and will remain on the table over the next 12 months. These issues include softness in higher acuity and elective surgeries, reimbursement overhang from Washington and private payors, potential impact from doc fix, and a continued but slow economic recovery. Given the recent run up in HCA, and what we see as a lack of near-term catalysts, we believe the risk/reward profile is not as compelling."

To see more ratings on HCA, Click Here

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi Downgrades Arch Coal (ARCH) to Neutral
• OTR Global Downgrades Capri Holdings (CPRI) to Mixed
• Goldman Sachs Downgrades Mitsubishi Estate Co., Ltd. (8802:JP) (MITEY) to Neutral